Organometallics
Article
82.63; H, 5.88. Mp: 130 °C. IR (KBr, cm−1): 3022 (CH)Ph, 2924, 2851
(CH2), 1596, 1498, 1443 (CC)Ph, 1025 (CC)Cp, 979 (CCH),
744, 705 (CH). EI-MS m/z (%): 623 (79) [M+], 416 (94)
[{(C6H5)4CBD}Co+], 266 (67) [CoCp(CHCH)2CHT+]. 1H
Yield: 31 mg (0.05 mmol) orange-red solid material (67.4%). Mp:
230 °C. Anal. Calcd for C46H41Co (H2O) (M = 670.78): C, 82.37; H,
6.46. Found: C, 82.44; H, 6.82. IR (KBr, cm−1): 3084, 3025 (CH)Ph,
2918, 2855 (CH3), 1654 (CC), 1618, 1516, 1438 (CC)Ph, 1380
(CH3), 1110, 1018 (CC)Cp, 952 (CCH), 809 (CH). EI-MS (m/z
(%)): 652 (100) [M+], 471.6 (43) [{(4-CH3C6H4)4CBD}Co+], 240.3
(91) [CoCp-(CHCH)CHT+], 57 (79) [Co+]. 1H NMR (200 MHz,
CD2Cl2, δ in ppm): 2.26 (s, 12 H, CH3), 2.30 (d, 3J = 7.10 Hz, 2 H, 1
H-7′exo/endo), 4.62 (m, 2 H, Cp), 4.67 (m, 2 H, Cp), 5.21 (dt, 3J = 9.03
3
NMR (200 MHz, CD2Cl2, δ in ppm): 2.59 (d, J = 7.08 Hz, 2 H,
H-7′exo/endo), 4.67 (m, 3J = 2.00 Hz, 2 H, Cp), 4.69 (m, 2 H, Cp), 5.44
(m, 7.20 Hz, 1 H, H-6′), 5.75 (d, 3J = 15.63 Hz, 1 H, H-4), 6.02−6.32
3
(m, 5 H, H-1/2/3, H-2′/5′), 6.56 (2dd, J = 10.07 Hz, 5.86 Hz, 4.27
Hz, 2 H, H-3′/4′), 7.16−7.24 (m, 12 H, Hm,p), 7.36−7.42 (m, 8 H,
Ho). 13C NMR (50 MHz, CD2Cl2, δ in ppm): 28.18 (C-7′), 76.00
(CBD), 81.29 (Cp), 84.88 (Cp), 96.06 (Cq-Cp), 122.74 (C-6′),
126.01 (C-4), 126.52 (Cp), 127.06, 127.88, 128.84, 130.32, 132.97 (C-
2′/5′, C-1,2,3), 128.28 (Cm), 129.10 (Co), 131.12 (C-3′/4′), 132.63
(C-1′), 136.24 (Ci).
3
Hz, 7.20 Hz, 1 H, H-6′), 5.93 (d, J = 5.10 Hz, 1 H, H-2′), 6.09 (s, 2
3
3
H, H-1/2), 6.18 (dd, J = 9.28 Hz, 3.78 Hz, H, C-5′), 6.52 (2dd, J =
9.77 Hz, 4.88 Hz, 4.30 Hz, 2 H, H-3′/4′), 6.98 (d, 3J = 7.81 Hz, 8 H,
Hm), 7.26 (d, 3J = 8.06 Hz, 8 H, Ho). 13C NMR (50 MHz, CD2Cl2, δ
in ppm): 21.21 (CH3); 27.51 (C-7′), 75.42 (CBD), 80.64 (Cp), 84.77
(Cp), 95.32 (Cq-Cp), 122.01 (C-6′), 123.60 (C-2), 125.02 (C-2′),
127.29 (C-5′), 128.62 (Cm), 128.67 (Co), 129.08 (C-1), 129.57 (C-
4′), 130.81 (C-3′), 132.20 (C-1′), 133.05 (Cp), 135.93 (Ci).
( E , E , E ) - 1 - [ ( T e t r a p h e n y l - η 4 - c y c l o b u t a d i e n e ) ( η 5 -
cyclopentadienediyl)cobalt(I)]-6-(cyclohepta-1′,3′,5′-trien-1′-yl)-
1,3,5-hexatriene (11): {(C6H5)4CBD}CoCp-(E)-(CHCH)2CHO
(8; 41 mg, 0.07 mmol), cyclohepta-1′,3′,5′-trien-1′-ylmethylphosph-
onate diethyl ester (34 mg, 0.14 mmol), benzene (4 mL), soda lye
(50%) (4 mL), 4 h reflux, column chromatography Al2O3 neutral, 5%
water, hexane/diethyl ether 3/1.
(E)-1-[{Tetrakis(4-methoxyphenyl)-η4-cyclobutadiene}(η5-
cyclopentadienediyl)cobalt(I)]-2-(cyclohepta-1′,3′,5′-trien-1′-yl)-
ethene (9d): {(4-MeOC6H4)4CBD}CoCpCHO (6d; 30 mg, 0.05
mmol), cyclohepta-1′,3′,5′-trien-1′-ylmethylphosphonate diethyl ester
(27 mg, 0.11 mmol), benzene (3 mL), 50% soda lye (3 mL), 4 h
reflux, column chromatography Al2O3 neutral, 5% water/95% toluene.
Yield: 32 mg (0.04 mmol, 93.6%) orange-red solid material. Mp:
226 °C. Anal. Calcd for C46H41CoO4 (Et2O) (M = 790.88): C, 75.93;
H, 6.50. Found: C, 75.69; H, 6.78. EI-MS (m/z (%)): 716.5 (100)
[M+], 702 (M+ − CH2), 535.2 (12) [{(4-CH3OC6H4)4CBD}Co+],
240.1 (52) [CoCp(CHCH)CHT+]. IR (KBr, cm−1): 2999, 2952,
2928 (CH2, CH3), 2833 (COCH3), 1607, 1513, 1450 (CC)Ph, 1382
(CH3), 1243 (COCH3), 1173, 1033 (CC)Cp, 954 (CCH), 809
(CH). 1H NMR (200 MHz, CD2Cl2, δ in ppm): 2.34 (d, 3J = 7.08 Hz,
2 H, H-7′exo/endo), 3.77 (s, 12 H, OCH3), 4.62 (m, 2 H, Cp), 4.68 (m,
2 H, Cp), 5.24 (dt, 3J = 9.27 Hz, 7.00 Hz, 1H, H-6′), 5.96 (d, 3J = 5.37
Hz, 1 H, H-2′), 6.07 (d, 3J = 15.78 Hz, 1 H, H-2), 6.16 (d, 3J = 15.78
Hz, 1 H, H-1), 6.18 (dd, 3J = 9.28 Hz, 4.40 Hz, 1 H, C-5′), 6.53 (2dd,
3J = 10.55 Hz, 5.58 Hz, 4.80 Hz, 2 H, H-3′/4′), 6.72 (d, 3J = 8.79 Hz, 8
Yield: 41 mg (0.06 mmol, 91%) orange-red solid material. Anal.
Calcd for C46H37Co (4H2O) (720.79): C, 76.65; H, 6.29. Found: C,
76.70; H, 6.47. Mp: 129 °C. IR (KBr, cm−1): 3079, 3055, 3021
(CH)Ph, 2924, 2850 (CH2), 1724, 1675 (CC), 1597, 1498, 1443
(CC)Ph, 1156, 1026 (CC)Cp, 993 (CCH), 744, 705 (CH). EI-
MS (m/z (%)): 648 (17) [M+], 415 (13) [{(C6H5)4CBD}Co+], 356
+
(55) [{(C6H5)4CBD}+], 278 (14) [CoCp(CHCH)3C6H6 ]. 1H
3
NMR (200 MHz, CD2Cl2, δ in ppm): 2.63 (d, J = 7.14 Hz, 2 H, H-
3
7′exo/endo), 4.67 (m, 2 H, Cp), 4.70 (m, 2 H, Cp), 5.44 (dt, J = 8.80
Hz, 6.80 Hz, 1 H, H-6′), 5.75 (d, 3J = 14.00 Hz, 1 H, H-6), 6.02−6.37
(m, 6 H, H-2′/5′, H-2/3/4/5), 6.53−6.61 (m, 3 H, H-1, H-3′/4′),
7.14−7.25 (m, 12 H, Hm,p), 7.36−7.43 (m, 8 H, Ho). 13C NMR (50
MHz, CD2Cl2, δ in ppm): 28.14 (C-7′), 75.94 (CBD), 81.11 (Cp),
85.12 (Cp), 96.03 (Cq-Cp), 122.70 (C-6′), 126.49 (Cp), 126.49,
127.88, 128.93, 132.06, 133.51, 134.44 (C-2′/5′, C-2/3/4/5), 126.83
(C-6), 128.25 (Cm), 129.05 (Co), 130.53 (C-1), 130.91 (C-4′), 131.04
(C-3′), 132.81 (C-1′), 136.21 (Ci).
H, Hm), 7.30 (d, 3J = 8.79 Hz, 8 H, Ho). 13C NMR (50 MHz, CD2Cl2,
δ in ppm): 27.87 (C-7′), 55.54 (OCH3), 75.29 (CBD), 80.70 (Cp),
84.86 (Cp), 95.58 (Cq-Cp), 113.77 (Cm), 122.22 (C-6′), 124.22 (C-
2), 125.14 (C-2′), 127.65 (C-5′), 128.45 (Ci), 129.13 (C-1), 129.86
(C-4′), 130.07 (Co), 131.14 (C-3′), 132.55 (C-1′), 158.43 (Cp).
(E)-1-[Tetrakis(4-dimethylaminophenyl)(η4-cyclobutadiene)(η5-
cyclopentadienediyl)cobalt(I)]-2-(cyclohepta-1′,3′,5′-trien-1′-yl)-
ethene (9e). {(4-(CH3)2NC6H4)4CBD}CoCpCHO (6e; 80 mg, 0.12
mmol), cyclohepta-1′,3′,5′-trien-1′-ylmethylphosphonate diethyl ester
(57 mg, 0.42 mmol), benzene (6 mL), 50% soda lye (3 mL), 10 h
reflux, column chromatography Al2O3 neutral, 5% water, hexane/
diethyl ether 1/1.
(E)-1-[(Tetrakis(4-chlorophenyl)-η4-cyclobutadiene)(η5-
cyclopentadienediyl)cobalt(I)]-2-(cyclohepta-1′,3′,5′-trien-1′-yl)-
ethene (9b). {(4-ClC6H4)4CBD}CoCpCHO (6b; 100 mg, 0.15
mmol), cyclohepta-1′,3′,5′-trien-1′-ylmethylphosphonate diethyl ester
(90 mg, 0.36 mmol), benzene (4 mL), 50% soda lye (4 mL), 2.5 h
reflux, column chromatography Al2O3 neutral, 5% water, hexane/
diethyl ether 5/1.
Yield: 110 mg (0.15 mmol, 96.5%) orange-red solid material. Anal.
Calcd for C42H29Cl4Co (0.5H2O) (M = 743.45): C, 67.85; H, 3.98.
Found: C, 67.99; H, 4.24. Mp: 190 °C. IR (KBr, cm−1): 3017 (CH)Ph,
2922, 2851 (CH2), 1601, 1495, 1443 (CC)Ph, 1117, 1011 (C
C)Cp, 1081 (CCl), 952 (CCH), 818 (CH). EI-MS (m/z (%)): 736
(2), 734 (6), 732 (4) [M+ − (Cl, isotopic pattern) 722 (2), 720 (6),
Yield: 48 mg (0.06 mmol) red solid material (53.1%). Mp: 305 °C.
Anal. Calcd for C50H53CoN4 (1/2CH2Cl2) (M = 811.40): C, 74.75; H,
6.71, N 6.90. Found: C, 75.20; H, 6.86, N 7.02. EI-MS (m/z (%)):
767.9 (100) [M+], 586.9 (12) [{(4-(CH3)2NC6H4)4CBD}Co+], 528.1
(26) [{(4-(CH3)2NC6H4)4CBD}+], 240.1 (26) [CoCp(CHCH)-
CHT+]. IR (KBr, cm−1): 3085, 3015 (CH)Ph, 2993, 2976, 2888, 2850
(CH2,CH3), 1609, 1524, 1444 (CC)Ph, 1388 (CH3), 1195 (CN),
1126, 1004 (CC)Cp, 945 (CCH), 814 (CH). 1H NMR (200
1
718 (4) [M+ − CH2 − (Cl-isotopic pattern)], 91 (100) [CHT+]. H
3
NMR (200 MHz, CD2Cl2, δ in ppm): 2.36 (d, J = 7.08 Hz, 2 H, H-
3
7′exo/endo), 4.65 (m, 2 H, Cp), 4.71 (m, 2 H, Cp), 5.25 (dt, J = 9.00
Hz, 7.10 Hz, 1 H, H-6′), 6.01 (dd, 3J = 4.15 Hz, 2.00 Hz, 1.71 Hz, 1 H,
H-2′), 6.04 (d, 3J = 16.11 Hz, 1 H, H-2), 6.15 (d, 3J = 16.11 Hz, 1 H,
H-1), 6.21 (ddd, 3J = 9.34 Hz, 3.60 Hz, 2.00 Hz, 1 H, H-5′), 6.55 (2dd,
3J = 8.85 Hz, 4.40 Hz, 3.15 Hz, 2 H, H-3′/4′), 7.17 (d, 3J = 8.79 Hz, 8
3
MHz, CD2Cl2, δ in ppm): 2.34 (d, J = 7.22 Hz, 2 H, H-7′exo/endo),
2.92 (s, 24 H, N(CH3)2), 4.58 (m, 2 H, Cp), 4.64 (m, 2 H, Cp), 5.24
(dt, 3J = 8.23 Hz, 7.20 Hz, H, H-6′), 5.94 (d, 3J = 5.82 Hz, 1 H, H-2′),
6.07 (d, 3J = 16.00 Hz, H, H-2), 6.10−6.20 (m, H, H-5′), 6.20 (d, 3J =
16.00 Hz, 1 H, H-1), 6.40−6.60 (m, 2 H, H-3′/4′), 6.54 (d, 3J = 11.67
H, Hm), 7.28 (d, 3J = 8.79 Hz, 8 H, Ho). 13C NMR (50 MHz, CD2Cl2,
δ in ppm): 27.69 (C-7′), 74.66 (CBD), 81.05 (Cp), 85.22 (Cp), 96.23
(Cq-Cp), 122.30 (C-2), 127.84 (C-6′), 126.24 (C-2′), 127.84 (C-5′),
128.73 (Cm), 130.12 (Co), 130.44 (C-4′), 130.58 (C-1), 131.09 (C-
3′), 131.85 (C-1′), 132.26 (Ci), 134.330 (Cp).
3
Hz, 8 H, Hm), 7.26 (d, J = 11.67 Hz, 8 H, Ho). 13C NMR (50 MHz,
CD2Cl2, δ in ppm): 27.99 (C-7′), 40.61 (N(CH3)2), 75.64 (CBD),
80.36 (Cp), 84.54 (Cp), 95.26 (Cq-Cp), 112.10 (Cm), 122.09 (C-6′),
124.40 (Ci), 124.51 (C-2′), 125.35 (C-5′), 127.48 (C-2), 128.31 (C-
4′), 129.37 (C-3′), 129.72 (Co), 131.22 (C-1), 132.86 (C-1′), 149.12
(Cp).
General Synthesis of Cationic, Mononuclear (Ar4CBD)CoCp
Complexes with Tropylium Substitution. The cycloheptatrienyl-
substituted complexes 4b,c, 9a−e, 10, and 11 were dissolved in
(E)-1-[(Tetra-p-tolyl-η4-cyclobutadiene)(η5-cyclopentadienediyl)-
cobalt(I)]-2-(cyclohepta-1′,3′,5′-trien-1′-yl)ethene (9c): {(4-
CH3C6H4)4CBD}CoCpCHO (6c) (40 mg, 0.07 mmol), Cyclo-
hepta-1′,3′,5′-trien-1′-ylmethylphosphonate diethyl ester (40 mg,
0.16 mmol), benzene (5 mL), 50% soda lye (5 mL), 6 h reflux,
column chromatography Al2O3 neutral, 5% water, hexane/diethyl
ether 2/1.
6922
dx.doi.org/10.1021/om300710x | Organometallics 2012, 31, 6911−6925